CareDx director granted 9,795 RSUs
COURNOYER CHRISTINE reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
COURNOYER CHRISTINE reported acquisition or exercise transactions in this Form 4 filing.
CareDx, Inc. director Christine Cournoyer received a grant of 9,795 shares of common stock in the form of restricted stock units. The RSUs vest 100% on the earlier of one year after the grant date or immediately before the first annual meeting after the grant, subject to continued service. Following this grant, she directly holds 58,943 shares.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 9,795 | $0.00 | $0.00 |
Footnotes (1)
- F1. The reported securities are represented by restricted stock units ("RSUs"), of which the RSUs vests 100% on the earlier of the one year anniversary of grant or the day immediately before the first Annual Meeting that occurs after the grant date., subject to the Reporting Person's continuous service on each applicable vesting date.
Key Figures
Key Terms
restricted stock units financial
RSUs financial
Annual Meeting financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did CareDx (CDNA) report for Christine Cournoyer?
What are the vesting terms of the RSUs granted to the CareDx (CDNA) director?
Was the CareDx (CDNA) Form 4 transaction a market purchase or sale?
Does the CareDx (CDNA) Form 4 indicate any derivative security activity?
AI-generated analysis. How Rhea-AI works. Not financial advice.